Dr.
Iqra Rahim (Pharm.D) serves as a Clinical Research Associate. She holds a degree in Doctor of Pharmacy degree from Hamdard University, Islamabad, Pakistan. With over four years of dedicated experience in clinical research, she has contributed extensively to treatment and vaccine trials, including the CanSino and Livzon COVID-19 vaccine studies, the ACTIV-2d COVID-19 treatment trial, as well as oncology and cardiovascular studies such as Perjeta and ASPIRE-AF.
She demonstrates comprehensive expertise in trial initiation, participant screening and randomization, investigational product (IP) management, clinical documentation, and regulatory compliance, consistently adhering to Good Clinical Practice (GCP) and protocol requirements. With5`1 a strong commitment to advancing clinical research, Iqra Rahim combines precision, professionalism, and teamwork to drive high-quality outcomes across diverse research projects.
Contact Form